Newsroom

NEW YORK--(BUSINESS WIRE)--MN8 Energy Holdings LLC (MN8), a scaled power platform developing, owning, and operating energy assets for enterprise customers, with over 4.3 GW of operating and under construction renewable capacity across 29 states, and Greenbacker Renewable Energy Company LLC (Greenbacker), an Independent Power Producer (IPP) that owns a ~1.9 GW fleet of operating and under construction renewable energy assets across 22 states, today announced a definitive agreement under which MN...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

WALTHAM, Mass.--(BUSINESS WIRE)--Affinia Therapeutics (“Affinia”), an innovative clinical-stage gene therapy company with a pipeline of first-in-class and/or best-in-class adeno-associated virus (AAV) gene therapies initially for devastating cardiovascular diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation for AFTX-201 for the treatment of BAG3-associated dilated cardiomyopathy (DCM). A potential best-in-class investigational genetic m...

SAN ANTONIO--(BUSINESS WIRE)--Howard Midstream Energy Partners, LLC (the “Company”) today announced that it is commencing an offering (the “Offering”) of $600 million of senior notes due 2035 (the “2035 Notes”). The 2035 Notes will be issued in a private offering exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). The Company will use the net proceeds from the Offering to (i) fund the repayment of a portion of outstanding borrowings under the Company’s...

CONCORD TOWNSHIP, Ohio--(BUSINESS WIRE)--Ranpak to Hold Conference Call to Discuss Second Quarter 2026 Results on Thursday, July 30, 2026....

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its second quarter 2026 financial results and provide recent corporate updates on August 6, 2026, before the opening of U.S. equity markets. The announcement will be followed by a conference call and webcast at 8:00 a.m. ET (8:00 p.m. HKT). Conference Call and Webcast Information The live webcast can be accessed by visiting the Company's website at http://ir.zailaboratory...

NEW YORK & MIAMI--(BUSINESS WIRE)--Madison River Capital ("MRC"), a lower middle market private equity firm, today announced a strategic investment in Pro-Max ("Pro-Max" or the "Company"), a leading provider of structural repair, restoration, painting, and roofing solutions for condominium and commercial properties. The investment will support Pro-Max's geographic expansion, broadened service capabilities, and continued team development as the Company capitalizes on growing demand for high-qual...

BUFFALO, N.Y.--(BUSINESS WIRE)--Gibraltar Industries, Inc. (Nasdaq: ROCK), a leading manufacturer and provider of products and services for the residential, agtech and infrastructure markets, announced today that it expects to release its second quarter 2026 financial results at approximately 7:30 a.m. ET on Wednesday, August 5, 2026. It also expects to discuss the results on a conference call that will be webcast live that same day starting at 9:00 a.m. ET. Hosting the call will be Chief Execu...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced topline results for the global Phase 3 SHASTA-3 and SHASTA-4 clinical studies of plozasiran in patients with severe hypertriglyceridemia (sHTG), a condition that significantly increases the risk of acute pancreatitis (AP), which is associated with repeated hospital admissions and can be fatal. SHASTA-3 and SHASTA-4 successfully met the primary endpoint of triglyceride reduction versus placebo and m...

LOS ANGELES--(BUSINESS WIRE)--Utz Brands, Inc. Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights – UTZ...